[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100615011":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":26,"centralContacts":30,"locations":26,"responsibleParty":39,"collaborators":26,"id":41,"slug":42,"hasResults":43,"nctId":44,"briefTitle":45,"officialTitle":46,"acronym":47,"eligibilityCriteria":48,"healthyVolunteers":43,"sex":49,"minAge":50,"maxAge":51,"enrollmentInfo":52,"targetDuration":26,"studyType":55,"phases":56,"briefSummary":58,"conditions":59,"keywords":26,"overallStatus":61,"whyStopped":26,"lastUpdateSubmitDate":62,"lastUpdatePostDateStruct":63,"startDateStruct":66,"completionDateStruct":68,"leadSponsor":70,"locationsCount":26},{"fullName":5,"class":6},"Mahidol University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"HILT group","EXPERIMENTAL","High-power laser therapy (iLUX® XP) was applied using a power output of 6 W, an energy density of 5 J\u002Fcm², and a spot size of 10 cm², delivering a total energy of 150 J per session. Treatment consisted of 6 sessions, administered twice per week for 3 weeks.",[13],"Device: High power Laser therapy",{"label":15,"type":16,"description":17,"interventionNames":18},"fESWT group","ACTIVE_COMPARATOR","Focused extracorporeal shock wave therapy (fESWT) using the DUOLITH® SD1 (STORZ Medical) was applied at a frequency of 4 Hz, starting at an energy flux density of 0.2 mJ\u002Fmm² and gradually increased as tolerated. Each session consisted of 2,000 shocks, for a total of 3 sessions (one session per week)",[19],"Device: Focused extracorporeal shock wave therapy",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DEVICE","High power Laser therapy","High-power laser therapy (iLUX® XP) was applied using a power output of 6 W, an energy density of 5 J\u002Fcm², and a spot size of 10 cm², delivering a total energy of 150 J per session. Treatment consisted of 6 sessions, administered twice per week for 3 weeks",[9],null,{"type":22,"name":28,"description":17,"armGroupLabels":29,"otherNames":26},"Focused extracorporeal shock wave therapy",[15],[31,36],{"name":32,"role":33,"phone":34,"phoneExt":26,"email":35},"Peerada Eurcherdkul, Doctor of Medicine","CONTACT","+6692-272-0652","eurpeerada@gmail.com",{"name":37,"role":33,"phone":38,"phoneExt":26,"email":26},"Suttinon Jitjai, Dortor of Medicine","+89-463-3401",{"type":40,"investigatorFullName":26,"investigatorTitle":26,"investigatorAffiliation":26,"oldNameTitle":26,"oldOrganization":26},"SPONSOR","100615011","a-single-blind-randomized-controlled-study-comparing-the-efficacy-of-high-intensity-laser-therapy-and-focused-extracorporeal-shock-wave-therapy-in-patients-with-plantar-fasciitis-100615011",false,"NCT07287046","A Single-Blind Randomized Controlled Study Comparing the Efficacy of High-Intensity Laser Therapy and Focused Extracorporeal Shock Wave Therapy in Patients With Plantar Fasciitis","A Comparison of Efficacy Between High-intensity Laser Therapy and Focused Extracorporeal Shock Wave Therapy in Patient With Plantar Fasciitis; Single Blinded Randomize Controlled Study","HILT","Inclusion Criteria:\n\n* Patients aged 18-70 years\n* Pain was worse in the initial step after and an extended period of rest\n* Pain was decreased initially after the first steps but exacerbated with increased activity\n* VAS ≥ 4\n* Pain was localized and sharp but not radiating,\n* Pain was reproduced with palpation of the plantar fascia\n\nExclusion Criteria:\n\n* Have Wound\u002FInfection\u002Ftumor in treatment area\n* History of foot trauma in 3 months\n* History of intervention at plantar fascia in 6 months such as Ultrasound therapy, steroid injection, surgery or botulinum toxin injection\n* Pain medication within one week before participation\n* Patient wasn't desired to participate in the study","ALL","18 Years","70 Years",{"count":53,"type":54},28,"ESTIMATED","INTERVENTIONAL",[57],"NA","This randomized controlled trial aims to evaluate the efficacy of High-Intensity Laser Therapy (HILT) and Focused Extracorporeal Shock Wave Therapy (fESWT) in reducing pain in patients with plantar fasciitis. The study also examines the effects of HILT and fESWT on health-related outcomes, including VAS-FA, FFI, plantar fascia thickness, and adverse events.\n\nResearchers will compare HILT with fESWT as treatment options for patients with plantar fasciitis.\n\nParticipants will receive either HILT or fESWT along with an exercise program. They will attend follow-up visits to assess outcomes at 1, 2, 3, 6, and 12 weeks after the first treatment.",[60],"Plantar Fasciitis","NOT_YET_RECRUITING","2026-03-20",{"date":64,"type":65},"2026-03-25","ACTUAL",{"date":67,"type":54},"2026-02-28",{"date":69,"type":54},"2027-02-20",{"name":5,"class":6}]